Symrise (FRA:SY1) Given a €81.00 Price Target at Morgan Stanley

Morgan Stanley set a €81.00 ($94.19) price target on Symrise (FRA:SY1) in a research note published on Monday, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

Several other brokerages have also commented on SY1. Nord/LB set a €58.00 ($67.44) price target on Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Thursday, May 2nd. Independent Research set a €215.00 ($250.00) price target on Munchener Ruckvers and gave the company a neutral rating in a research note on Wednesday, May 8th. Sanford C. Bernstein began coverage on Beigene in a research note on Tuesday, June 4th. They issued an outperform rating and a $201.00 price target on the stock. Credit Suisse Group raised ConocoPhillips from a neutral rating to an outperform rating and set a $75.00 price target on the stock in a research note on Tuesday, April 30th. Finally, Barclays reaffirmed a hold rating and issued a $52.00 price target on shares of Biohaven Pharmaceutical in a research note on Tuesday, March 19th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and six have assigned a buy rating to the company. The stock presently has a consensus rating of Hold and a consensus price target of €79.50 ($92.44).

FRA SY1 opened at €83.32 ($96.88) on Monday. The stock’s fifty day moving average is €85.49. Symrise has a fifty-two week low of €56.96 ($66.23) and a fifty-two week high of €73.48 ($85.44).

About Symrise

Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.

Recommended Story: What is meant by holder of record?

Analyst Recommendations for Symrise (FRA:SY1)

Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with's FREE daily email newsletter.